Rising Pharmaceuticals will unveil the first generic version of the Ultramicrosize Griseofulvin tablets USP 25mg and 250mg strengths, which are an FDA approved generic version of PEDiNOL Pharmacal's Gris-PEG(R).
Subscribe to our email newsletter
Used to treat fungus infections, the Ultramicrosize Griseofulvin tablets had sales nearly of $16.7m for the twelve months ended 30 June 2012 in the US market, according to IMS Health data.
Rising Pharmaceuticals is a finished dosage form generics subsidiary of ACETO Corporation, which markets, sells and distributes products for human health, pharmaceutical ingredients and performance chemicals.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.